Evidence suggests IGFBP5 plays a prominent role in the advancement of epithelial cancers including, but not limited to, ovarian, breast endometrioid, prostate, pancreatic, and gastric cancers as well as melanoma and glioblastoma (12). Here, IGFBP5 is linked to melanoma.